Cytokinetics, Inc. (CYTK)

[H2R]

CYTK is expecting ALS Ph III in a couple of weeks. It could be a bit longer. Maybe three? Four? Not much more I gather, given the last CC.

And the stock is dropping? I hope it's not some leaks, but a continuation of the funding with little else in terms of foresight.

If ALS Ph III top line comes out positive, this should change. And I do believe that the chances for success in the VITALITY-ALS trial are good.

This ought to be an interesting month for CYTK!!!